+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Flu Drug"

H3N2 infection - Pipeline Insight, 2024 - Product Thumbnail Image

H3N2 infection - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
Cold and Flu Drugs Companies in China - Product Thumbnail Image

Cold and Flu Drugs Companies in China

  • Report
  • July 2023
  • 50 Pages
  • China
From
Cold and Flu Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Cold and Flu Drugs Industry Forecasts - China Focus

  • Report
  • July 2023
  • 104 Pages
  • China
From
Cold and Flu Drugs Markets in China - Product Thumbnail Image

Cold and Flu Drugs Markets in China

  • Report
  • July 2023
  • 204 Pages
  • China
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Flu Drug market is a subset of the Infectious Diseases Drugs market, which focuses on the development and sale of drugs to treat influenza. Flu drugs are typically antiviral medications that work to reduce the severity and duration of the flu virus. These drugs are typically taken orally or through an injection, and are used to treat both seasonal and pandemic flu. Commonly prescribed flu drugs include oseltamivir, zanamivir, and peramivir. In addition to antiviral medications, the Flu Drug market also includes vaccines, which are used to prevent the flu virus from taking hold in the body. Vaccines are typically administered through an injection, and are recommended for people of all ages. The Flu Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the companies in the market include GlaxoSmithKline, Sanofi, Novartis, Merck, and Pfizer. Show Less Read more